Vimarsana
Biggest News Aggregation in the World

Inflarx Commitment Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inflarx Commitment Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inflarx Commitment Program Today - Breaking & Trending Today

InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators - Vimarsana News

InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators

Published: May 21, 2024

JENA, Germany, May 21, 2024 -- InflaRx N.V. , a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced data presented at the American...

Source: marketscreener.com
Related Topics:
San DiegoUnited StatesInflarx GmbRegina LutzCamilla ChongLaurie DoyleJan MedinaKatja ArnoldGlobenewswire IncInflarx Pharmaceuticals IncInflarx Commitment ProgramDrug AdministrationAmerican Thoracic SocietyInternational ConferenceEuropean Medicines AgencyMc ServicesThoracic SocietyBaricitinib Dramatically Improves MortalityCritically IllAcute Respiratory FailureChief Medical OfficerFact SheetHealthcare ProvidersSafety InformationMarketing Authorization Application
InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients - Vimarsana News

InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients

Published: January 25, 2024

InflaRx to cover costs of GOHIBIC for patients who are treated in line with its Emergency Use Authorization but do not survive. InflaRx is determined to support broader access to GOHIBIC for eligible...

Source: marketscreener.com
Related Topics:
United StatesLaurie DoyleChristian SandrockRegina LutzNielsc RiedemannInflarx GmbKatja ArnoldExchange CommissionInflarx Commitment ProgramCommitment ProgramEuropean Medicines AgencyInflarx Pharmaceuticals IncCenters For DiseaseUc Davis HealthMc ServicesDrug AdministrationDivision ViceEmergency Use AuthorizationDisease ControlDivision Vice ChairInternal MedicineCritical CareChief Executive OfficerLancet RespiratoryHealthcare Facilities